Deletion of Histone Deacetylase 3 Reveals Critical Roles in S Phase Progression and DNA Damage Control

Molecular Cell

Volumn 30, Issue 1, 2008, Pages 61-72

  Bhaskara, Srividya ^a   Chyla, Brenda J ^a   Amann, Joseph M ^a   Knutson, Sarah K ^a   Cortez, David ^a,b   Sun, Zu Wen ^a,b   Hiebert, Scott W ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

CELLCYCLE; DNA

Indexed keywords

CRE RECOMBINASE; DOUBLE STRANDED DNA; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE INHIBITOR; NUCLEAR RECEPTOR COREPRESSOR; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR;

ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; EMBRYO; ENZYME INACTIVATION; HUMAN; HUMAN CELL; INTERPHASE; MITOSIS; MOUSE; NONHUMAN; PROTEIN ENGINEERING; PROTEIN PHOSPHORYLATION; TUMOR CELL;

ANIMALS; APOPTOSIS; CAFFEINE; CELLS, CULTURED; DNA DAMAGE; DNA REPAIR; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HUMANS; MICE; MICE, KNOCKOUT; MITOSIS; NEOPLASMS; NIH 3T3 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PHOSPHODIESTERASE INHIBITORS; RADIATION, IONIZING; S PHASE;

EID: 41549156540     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2008.02.030     Document Type: Article

References (58)

1. Altucci L., Clarke N., Nebbioso A., Scognamiglio A., and Gronemeyer H. Acute myeloid leukemia: therapeutic impact of epigenetic drugs. Int. J. Biochem. Cell Biol. 37 (2005) 1752-1762
2. Amann J.M., Nip J., Strom D.K., Lutterbach B., Harada H., Lenny N., Downing J.R., Meyers S., and Hiebert S.W. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol. Cell. Biol. 21 (2001) 6470-6483
3. Bartek J., Lukas C., and Lukas J. Checking on DNA damage in S phase. Nat. Rev. Mol. Cell Biol. 5 (2004) 792-804
4. Bartova E., Pachernik J., Harnicarova A., Kovarik A., Kovarikova M., Hofmanova J., Skalnikova M., Kozubek M., and Kozubek S. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases. J. Cell Sci. 118 (2005) 5035-5046
5. Benson L.J., Gu Y., Yakovleva T., Tong K., Barrows C., Strack C.L., Cook R.G., Mizzen C.A., and Annunziato A.T. Modifications of H3 and H4 during chromatin replication, nucleosome assembly, and histone exchange. J. Biol. Chem. 281 (2006) 9287-9296
6. Bernstein B.E., Tong J.K., and Schreiber S.L. Genomewide studies of histone deacetylase function in yeast. Proc. Natl. Acad. Sci. USA 97 (2000) 13708-13713
7. Bolden J.E., Peart M.J., and Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 5 (2006) 769-784
8. Byun T.S., Pacek M., Yee M.C., Walter J.C., and Cimprich K.A. Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes Dev. 19 (2005) 1040-1052
9. Camphausen K., and Tofilon P.J. Inhibition of histone deacetylation: a strategy for tumor radiosensitization. J. Clin. Oncol. 25 (2007) 4051-4056
10. Chang S., McKinsey T.A., Zhang C.L., Richardson J.A., Hill J.A., and Olson E.N. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol. Cell. Biol. 24 (2004) 8467-8476
11. Cortez D. Caffeine inhibits checkpoint responses without inhibiting the ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) protein kinases. J. Biol. Chem. 278 (2003) 37139-37145
12. Cortez D., Glick G., and Elledge S.J. Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. Proc. Natl. Acad. Sci. USA 101 (2004) 10078-10083
13. Duvic M., Talpur R., Ni X., Zhang C., Hazarika P., Kelly C., Chiao J.H., Reilly J.F., Ricker J.L., Richon V.M., and Frankel S.R. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood 109 (2007) 31-39
14. Fernandez-Capetillo O., and Nussenzweig A. Linking histone deacetylation with the repair of DNA breaks. Proc. Natl. Acad. Sci. USA 101 (2004) 1427-1428
15. Fischle W., Dequiedt F., Hendzel M.J., Guenther M.G., Lazar M.A., Voelter W., and Verdin E. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 9 (2002) 45-57
16. Gallinari P., Di Marco S., Jones P., Pallaoro M., and Steinkuhler C. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res. 17 (2007) 195-211
17. Gaymes T.J., Padua R.A., Pla M., Orr S., Omidvar N., Chomienne C., Mufti G.J., and Rassool F.V. Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?. Mol. Cancer Res. 4 (2006) 563-573
18. Gelmetti V., Zhang J., Fanelli M., Minucci S., Pelicci P.G., and Lazar M.A. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol. Cell. Biol. 18 (1998) 7185-7191
19. Gray S.G., and Ekstrom T.J. The human histone deacetylase family. Exp. Cell Res. 262 (2001) 75-83
20. Gregoire S., Xiao L., Nie J., Zhang X., Xu M., Li J., Wong J., Seto E., and Yang X.J. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol. Cell. Biol. 27 (2007) 1280-1295
21. Guenther M.G., Barak O., and Lazar M.A. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 21 (2001) 6091-6101
22. Hayashi S., and McMahon A.P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 244 (2002) 305-318
23. Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A., Yoshida M., Wang X.F., and Yao T.P. HDAC6 is a microtubule-associated deacetylase. Nature 417 (2002) 455-458
24. Insinga A., Minucci S., and Pelicci P.G. Mechanisms of selective anticancer action of histone deacetylase inhibitors. Cell Cycle 4 (2005) 741-743
25. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
26. Karagiannis T.C., and El-Osta A. Modulation of cellular radiation responses by histone deacetylase inhibitors. Oncogene 25 (2006) 3885-3893
27. Khochbin S., and Kao H.Y. Histone deacetylase complexes: functional entities or molecular reservoirs. FEBS Lett. 494 (2001) 141-144
28. Knutson S.K., Chyla B.J., Amann J.M., Bhaskara S., Huppert S.S., and Hiebert S.W. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. (2008) 10.1038/emboj.2008.51 Published online March 20, 2008
29. Kurz E.U., and Lees-Miller S.P. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst.) 3 (2004) 889-900
30. Lagger G., O'Carroll D., Rembold M., Khier H., Tischler J., Weitzer G., Schuettengruber B., Hauser C., Brunmeir R., Jenuwein T., and Seiser C. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21 (2002) 2672-2681
31. Lahm A., Paolini C., Pallaoro M., Nardi M.C., Jones P., Neddermann P., Sambucini S., Bottomley M.J., Lo Surdo P., Carfi A., et al. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc. Natl. Acad. Sci. USA 104 (2007) 17335-17340
32. Li J., Wang J., Wang J., Nawaz Z., Liu J.M., Qin J., and Wong J. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19 (2000) 4342-4350
33. Li Y., Kao G.D., Garcia B.A., Shabanowitz J., Hunt D.F., Qin J., Phelan C., and Lazar M.A. A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. Genes Dev. 20 (2006) 2566-2579
34. Linggi B.E., Brandt S.J., Sun Z.W., and Hiebert S.W. Translating the histone code into leukemia. J. Cell. Biochem. 96 (2005) 938-950
35. Lovejoy C.A., Lock K., Yenamandra A., and Cortez D. DDB1 maintains genome integrity through regulation of Cdt1. Mol. Cell. Biol. 26 (2006) 7977-7990
36. Lupardus P.J., Byun T., Yee M.C., Hekmat-Nejad M., and Cimprich K.A. A requirement for replication in activation of the ATR-dependent DNA damage checkpoint. Genes Dev. 16 (2002) 2327-2332
37. Lutterbach B., Westendorf J.J., Linggi B., Patten A., Moniwa M., Davie J.R., Huynh K.D., Bardwell V.J., Lavinsky R.M., Rosenfeld M.G., et al. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol. Cell. Biol. 18 (1998) 7176-7184
38. Marks P.A. Discovery and development of SAHA as an anticancer agent. Oncogene 26 (2007) 1351-1356
39. Marks P.A., and Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat. Biotechnol. 25 (2007) 84-90
40. Mello J.A., and Almouzni G. The ins and outs of nucleosome assembly. Curr. Opin. Genet. Dev. 11 (2001) 136-141
41. O'Connor O.A., Heaney M.L., Schwartz L., Richardson S., Willim R., MacGregor-Cortelli B., Curly T., Moskowitz C., Portlock C., Horwitz S., et al. Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies. J. Clin. Oncol. 24 (2006) 166-173
42. Prasanth S.G., Prasanth K.V., Siddiqui K., Spector D.L., and Stillman B. Human Orc2 localizes to centrosomes, centromeres and heterochromatin during chromosome inheritance. EMBO J. 23 (2004) 2651-2663
43. Prives C., and Hall P.A. The p53 pathway. J. Pathol. 187 (1999) 112-126
44. Smith S., and Stillman B. Purification and characterization of CAF-I, a human cell factor required for chromatin assembly during DNA replication in vitro. Cell 58 (1989) 15-25
45. Strom D.K., Nip J., Westendorf J.J., Linggi B., Lutterbach B., Downing J.R., Lenny N., and Hiebert S.W. Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle. J. Biol. Chem. 275 (2000) 3438-3445
46. Taddei A., Maison C., Roche D., and Almouzni G. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nat. Cell Biol. 3 (2001) 114-120
47. Takami Y., and Nakayama T. N-terminal region, C-terminal region, nuclear export signal, and deacetylation activity of histone deacetylase-3 are essential for the viability of the DT40 chicken B cell line. J. Biol. Chem. 275 (2000) 16191-16201
48. Taunton J., Hassig C.A., and Schreiber S.L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272 (1996) 408-411
49. Todaro G.J., and Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17 (1963) 299-313
50. Verreault A., Kaufman P.D., Kobayashi R., and Stillman B. Nucleosome assembly by a complex of CAF-1 and acetylated histones H3/H4. Cell 87 (1996) 95-104
51. Wang J., Hoshino T., Redner R.L., Kajigaya S., and Liu J.M. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc. Natl. Acad. Sci. USA 95 (1998) 10860-10865
52. Wen Y.D., Perissi V., Staszewski L.M., Yang W.M., Krones A., Glass C.K., Rosenfeld M.G., and Seto E. The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc. Natl. Acad. Sci. USA 97 (2000) 7202-7207
53. Wilson A.J., Byun D.S., Popova N., Murray L.B., L'Italien K., Sowa Y., Arango D., Velcich A., Augenlicht L.H., and Mariadason J.M. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 281 (2006) 13548-13558
54. Yoo H.Y., Shevchenko A., Shevchenko A., and Dunphy W.G. Mcm2 is a direct substrate of ATM and ATR during DNA damage and DNA replication checkpoint responses. J. Biol. Chem. 279 (2004) 53353-53364
55. Yoon H.G., Chan D.W., Huang Z.Q., Li J., Fondell J.D., Qin J., and Wong J. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22 (2003) 1336-1346
56. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., and Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110 (2002) 479-488
57. Zhang X., Yuan Z., Zhang Y., Yong S., Salas-Burgos A., Koomen J., Olashaw N., Parsons J.T., Yang X.J., Dent S.R., et al. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol. Cell 27 (2007) 197-213
58. Ziv Y., Bielopolski D., Galanty Y., Lukas C., Taya Y., Schultz D.C., Lukas J., Bekker-Jensen S., Bartek J., and Shiloh Y. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat. Cell Biol. 8 (2006) 870-876